1,2,3,4-Tetrahydro-2-naphthol - CAS 530-91-6
Catalog: |
BB028048 |
Product Name: |
1,2,3,4-Tetrahydro-2-naphthol |
CAS: |
530-91-6 |
Synonyms: |
1,2,3,4-tetrahydronaphthalen-2-ol; 1,2,3,4-tetrahydronaphthalen-2-ol |
IUPAC Name: | 1,2,3,4-tetrahydronaphthalen-2-ol |
Description: | 1,2,3,4-Tetrahydro-2-naphthol (CAS# 530-91-6) is a useful research chemical. |
Molecular Weight: | 148.20 |
Molecular Formula: | C10H12O |
Canonical SMILES: | C1CC2=CC=CC=C2CC1O |
InChI: | InChI=1S/C10H12O/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-4,10-11H,5-7H2 |
InChI Key: | JWQYZECMEPOAPF-UHFFFAOYSA-N |
Boiling Point: | 140 °C (12 mmHg) |
Melting Point: | 15.5 °C |
Density: | 1.112 g/cm3 |
Appearance: | Liquid |
MDL: | MFCD00045575 |
LogP: | 1.53620 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (33.33%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (33.33%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (66.67%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112374968-A | Application of supported catalyst in selective hydrogenation reaction of naphthalene derivative | 20201130 |
CN-112374969-A | Application of supported noble metal catalyst in selective hydrogenation reaction of naphthalene derivative | 20201130 |
CN-112973788-A | Process for catalytic selective oxidation of hydrocarbons | 20191213 |
CN-111393258-A | Method for synthesizing tetrahydronaphthalene-2-alcohol derivative compound | 20191203 |
WO-2021066144-A1 | Pharmaceutical drug containing heterocyclidene acetamide derivative | 20191004 |
PMID | Publication Date | Title | Journal |
23165153 | 20130225 | Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers | Chemico-biological interactions |
21276783 | 20110530 | Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids | Chemico-biological interactions |
19019256 | 20081120 | Engineering and Applications of fungal laccases for organic synthesis | Microbial cell factories |
18597534 | 20080801 | Stereoselective bioreduction of bulky-bulky ketones by a novel ADH from Ralstonia sp | The Journal of organic chemistry |
16885209 | 20061101 | An inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels | Molecular pharmacology |
Complexity: | 133 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 148.088815002 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 148.088815002 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 20.2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS